Increased Levels of Apolipoprotein D in Cerebrospinal Fluid and Hippocampus of Alzheimer's Patients

Abstract: Apolipoprotein D (apoD) is a member of the lipocalin family of proteins. Most members of this family are transporters of small hydrophobic ligands, although in the case of apoD, neither its physiological function(s) nor its putative ligand(s) have been unequivocally identified. In humans, apoD is expressed in several tissues, including the CNS, and its synthesis is greatly increased during regeneration of rat peripheral nerves. As apoD may have an important function in the nervous system and, particularly, in nerve regeneration, we measured immunoreactive apoD levels in the hippocampus and in CSF of patients with either Alzheimer's disease (AD) or other neuropathologies. In parallel, we determined the concentrations of apolipoprotein E (apoE), another apolipoprotein also implicated in nerve regeneration and in the etiology of AD. Levels of apoD but not apoE were increased in the hippocampus of AD patients compared with controls. ApoD concentrations, as determined by radioimmunoassay, were significantly increased in the CSF of AD patients (4.23 ± 1.58 µg/ml) and patients with other pathologies (3.29 ± 1.35 µg/ml) compared with those in the CSF of normal subjects (1.15 ± 0.71 µg/ml). Although the differences were smaller than for apoD, the mean apoE concentrations in the CSF of both groups of patients were also significantly higher than those of controls. In AD patients, apoD, but not apoE, levels in CSF and hippocampus increased as a function of inheritance of the ε4 apoE allele. This study therefore demonstrates that increased apoD levels in the hippocampus and in CSF are a marker of neuropathology, including that associated with AD, and are independent of apoE concentrations.

[1]  J. Simard,et al.  Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. , 1990, Endocrinology.

[2]  N. Maeda,et al.  Nerve Regeneration and Cholesterol Reutilization Occur in the Absence of Apolipoproteins E and A‐I in Mice , 1995, Journal of neurochemistry.

[3]  P. Alaupovic,et al.  Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system , 1973, FEBS letters.

[4]  W. Kohr,et al.  Cloning and expression of human apolipoprotein D cDNA. , 1986, The Journal of biological chemistry.

[5]  P. Amouyel,et al.  The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease , 1994, The Lancet.

[6]  E. Rassart,et al.  Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. , 1990, Journal of lipid research.

[7]  M C Peitsch,et al.  Is apolipoprotein D a mammalian bilin-binding protein? , 1992, The New biologist.

[8]  N. Maeda,et al.  Nerve Regeneration Occurs in the Absence of Apolipoprotein E in Mice , 1993, Journal of neurochemistry.

[9]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[10]  K. Blennow,et al.  Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. , 1994, Neuroreport.

[11]  T. Wisniewski,et al.  Apolipoprotein E : binding to soluble Alzheimer's β-amyloid , 1993 .

[12]  V. Armstrong,et al.  Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[13]  J. Gueriguian,et al.  A specific progesterone-binding component of human breast cyst fluid. , 1973, The Journal of biological chemistry.

[14]  M. Welch,et al.  Steroids and their conjugates in the mammalian brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Marcel,et al.  Protein polymorphism of a human plasma apolipoprotein D antigenic epitope. , 1989, Journal of lipid research.

[16]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Simard,et al.  Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. , 1992, Endocrinology.

[18]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[19]  G. Kostner,et al.  Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. , 1988, Biochimica et biophysica acta.

[20]  L. Notterpek,et al.  Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. , 1990, The Journal of biological chemistry.

[21]  G. Siest,et al.  Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease , 1997, Journal of the Neurological Sciences.

[22]  R. Patel,et al.  Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. , 1995, Neuroreport.

[23]  J. M. Morais Cabral,et al.  Arachidonic acid binds to apolipoprotein D: implications for the protein's function , 1995, FEBS letters.

[24]  F. Fujiyama,et al.  Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures , 1995, Brain Research.

[25]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[26]  A. Haase,et al.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.

[27]  R. Mahley,et al.  Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. , 1986, The Journal of biological chemistry.

[28]  C. López-Otín,et al.  Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. , 1994, The Journal of biological chemistry.

[29]  M. Spiegel-Adolf,et al.  Cerebrospinal fluid. , 1965, Progress in neurology and psychiatry.

[30]  Y. Shibuya,et al.  Preliminary findings on the variation of serum apolipoprotein levels in neural degenerative disorders , 1993, Journal of clinical laboratory analysis.

[31]  E. Rassart,et al.  Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures , 1991, FEBS letters.

[32]  S. Gauthier,et al.  Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies , 1994, Annals of neurology.

[33]  E. Rassart,et al.  Structure of the human apolipoprotein D gene promoter region. , 1993, Biochimica et biophysica acta.

[34]  Kathleen M. Smith,et al.  Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. , 1990, Journal of lipid research.

[35]  H. Müller,et al.  Regeneration‐associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. , 1990, The EMBO journal.

[36]  W. Ong,et al.  Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus , 1997, Neuroscience.

[37]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[38]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[39]  R. Mahley,et al.  Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E , 1994 .

[40]  D. Neville.  Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. , 1971, The Journal of biological chemistry.

[41]  E. Rassart,et al.  Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. , 1995, Brain research. Molecular brain research.

[42]  D. Clair,et al.  Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls , 1994, Neuroscience Letters.

[43]  Y. Marcel,et al.  Apolipoprotein D and cross-reacting human plasma apolipoproteins identified using monoclonal antibodies. , 1986, The Journal of biological chemistry.

[44]  E. Rassart,et al.  Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. , 1991, Journal of lipid research.